Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/08/06/2925434/0/en/MaxCyte-Reports-Second-Quarter-and-Half-Year-2024-Financial-Results-and-Updates-Full-Year-2024-Guidance.html
https://www.globenewswire.com/news-release/2024/08/06/2925422/0/en/MaxCyte-Reports-Second-Quarter-and-Half-Year-2024-Financial-Results-and-Updates-Full-Year-2024-Guidance.html
https://www.globenewswire.com/en/news-release/2024/07/09/2910747/0/en/MaxCyte-to-Report-Second-Quarter-2024-Financial-Results-on-August-6-2024.html
https://www.prnewswire.com/news-releases/porton-advanced-introduces-the-maxcyte-expert-gtx-flow-electroporation-instrument-continuing-to-provide-customers-with-end-to-end-cell-and-gene-therapy-cro--cdmo-services-302180310.html
https://www.globenewswire.com/news-release/2024/05/29/2889846/0/en/MaxCyte-to-Participate-in-William-Blair-44th-Annual-Growth-Stock-Conference.html
https://www.globenewswire.com/news-release/2024/05/22/2886464/0/en/MaxCyte-Signs-Strategic-Platform-License-Agreement-with-Legend-Biotech-to-Accelerate-Cell-Therapy-Discovery-and-Development.html
https://www.globenewswire.com/news-release/2024/05/07/2877199/0/en/MaxCyte-Reports-First-Quarter-2024-Financial-Results-and-Updates-2024-Guidance.html
https://www.globenewswire.com/news-release/2024/04/10/2860711/0/en/MaxCyte-to-Report-First-Quarter-2024-Financial-Results-on-May-7-2024.html
https://www.globenewswire.com/news-release/2024/04/02/2855927/0/en/MaxCyte-Signs-Strategic-Platform-License-with-Be-Biopharma-to-Support-the-Development-of-Engineered-B-Cell-Medicines-BCMs.html
https://www.globenewswire.com//news-release/2024/03/12/2845016/0/en/MaxCyte-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Reiterates-2024-Guidance.html